Ultragenyx Pharmaceutical (RARE) insider trading in the last 6 months

3 insiders sold $160K. No buys.

Quality Score-2Poor

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 3 tradesSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Form 4 filings, newest first

SellHoward Horn$108KChief Financial Officerat $15.27 on Oct 15, filed Oct 19

SellHoward HornChief Financial Officer$108Kat $15.27 on Oct 15, filed Oct 19

SellTheodore Alan Huizenga$2KSVP, Chief Accounting Officerat $13.99 on Sep 3, filed Sep 8

SellTheodore Alan HuizengaSVP, Chief Accounting Officer$2Kat $13.99 on Sep 3, filed Sep 8

SellCorazon D. Sanders$50KDirectorat $25.05 on Jun 15, filed Jun 15

SellCorazon D. SandersDirector$50Kat $25.05 on Jun 15, filed Jun 15

From SEC Form 4s, the newest filed Oct 19, 2026 · Insiders have 2 business days to file a trade

Pro members see every filing on RARE with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at Ultragenyx Pharmaceutical

Corazon D. SandersDirector · 1 sale
Howard HornChief Financial Officer · 1 sale
Theodore Alan HuizengaSVP, Chief Accounting Officer · 1 sale

Insider trades by person

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Questions about RARE's insider trades

As of Nov 10, 2026: Ultragenyx Pharmaceutical (RARE) has 3 insider filings on record in the last 6 months, the newest filed Oct 19, 2026. Its Quality Score is -2 (Poor). Scores as of 11:13 PM ET, 15 minutes behind.

Are RARE insiders buying or selling?

3 insiders sold $160K across 3 filings in the last 6 months. No open-⁠market buys on record. The newest filing: Howard Horn, Chief Financial Officer, sold $108K on Oct 15, 2026.

Who are RARE's biggest insider sellers?

By the dollars of their sales in the last 6 months: Howard Horn (Chief Financial Officer), 1 sale; Corazon D. Sanders (Director), 1 sale; Theodore Alan Huizenga (SVP, Chief Accounting Officer), 1 sale.

When did an RARE insider last buy?

No RARE insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Howard Horn on Oct 15, 2026.

Ultragenyx Pharmaceutical's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.

Ultragenyx Pharmaceutical (RARE) insider trading in the last 6 months

Form 4 filings, newest first

Who files at Ultragenyx Pharmaceutical

Questions about RARE's insider trades

Every insider trade, with its stock's score.